Stanford researchers have developed a system that assesses altered mental states in both human and animal subjects using neural biomarkers, allowing for repeatable cross-species studies of potential treatments for psychiatric and neurological disorders.
Stanford researchers have developed a novel technology using extracellular vesicles (EVs) to selectively suppress immune responses to AAV vectors, enabling safer and more effective gene therapy.
Stanford researchers have developed a novel blood-based diagnostic platform that leverages circulating bacteriophage DNA (phage cfDNA) to enable sensitive and highly specific detection of both overt and subclinical bacterial infections, while effectively discriminating them fr
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Stanford researchers have developed an innovative, non-invasive therapeutic strategy to treat myocardial fibrosis (MF), a key driver of arrhythmia and heart failure in LMNA-related dilated cardiomyopathy (LMNA-DCM).
Stanford researchers have developed Screen-GPT, an AI-powered multi-agent platform that automates CRISPR genetic screening by integrating diverse biological data to design libraries and prioritize targets through transparent, explainable, and scalable workflows.
Stanford researchers have developed a novel RNA-targeting therapeutic platform using CRISPR-Cas13d to selectively degrade oncogenic mRNA associated with uveal melanoma (UM), an aggressive and treatment-resistant form of eye cancer.
Stanford scientists have developed innovative methods for safely collecting, preserving, imaging, and molecularly profiling human brain tissue that remains on explanted intracranial electrodes used in neurosurgical procedures.
Stanford researchers have developed an Electrodialysis and Nitrate Reduction Process (EDNR) that produces high-purity ammonia from agricultural runoff.
Stanford researchers have developed a more sensitive and accurate pathogenic infection diagnosis method using intact genetically modified pathogens. Pathogen infection clinical diagnosis requires direct pathogen detection or the detection of pathogen specific antibodies.
Stanford researchers have developed a neuromonitoring-guided cognitive intervention that enhances working memory by dynamically identifying and reinforcing engagement of individualized brain networks in real time.